Literature DB >> 6468475

Problems and pitfalls in estimating average pharmacokinetic parameters.

E Martin, W Moll, P Schmid, L Dettli.   

Abstract

The problems of obtaining optimal average parameter estimates (APE) from experimental pharmacokinetic data are considered. Four different approaches, three parametric and one non-parametric tests, are compared, using selected individual alcohol concentration data. Pooling the raw data for estimating APE can obscure individual pharmacokinetic characteristics, whereas averaging individual parameter estimates (IPE) exposes unique statistical problems. Furthermore, careful consideration should be given to weighting procedures. The advantages and shortcomings of all four methods are discussed. It is concluded that none can be considered as a universally applicable statistical method in view of the purpose for which the information, derived from a set of data, e.g. an alcohol-kinetic study, is required.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6468475     DOI: 10.1007/bf00543492

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  6 in total

1.  Estimation of population characteristics of pharmacokinetic parameters from routine clinical data.

Authors:  L B Sheiner; B Rosenberg; V V Marathe
Journal:  J Pharmacokinet Biopharm       Date:  1977-10

2.  The pharmacokinetics of alcohol in human breath, venous and arterial blood after oral ingestion.

Authors:  E Martin; W Moll; P Schmid; L Dettli
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

3.  Evaluation of methods for estimating population pharmacokinetic parameters. II. Biexponential model and experimental pharmacokinetic data.

Authors:  L B Sheiner; S L Beal
Journal:  J Pharmacokinet Biopharm       Date:  1981-10

4.  Statistical moments in pharmacokinetics.

Authors:  K Yamaoka; T Nakagawa; T Uno
Journal:  J Pharmacokinet Biopharm       Date:  1978-12

5.  The application of statistical moment theory to the evaluation of in vivo dissolution time and absorption time.

Authors:  S Riegelman; P Collier
Journal:  J Pharmacokinet Biopharm       Date:  1980-10

6.  Evaluation of methods for estimating population pharmacokinetics parameters. I. Michaelis-Menten model: routine clinical pharmacokinetic data.

Authors:  L B Sheiner; S L Beal
Journal:  J Pharmacokinet Biopharm       Date:  1980-12
  6 in total
  7 in total

1.  Ethanol in human brain by magnetic resonance spectroscopy: correlation with blood and breath levels, relaxation, and magnetization transfer.

Authors:  G Fein; D J Meyerhoff
Journal:  Alcohol Clin Exp Res       Date:  2000-08       Impact factor: 3.455

2.  Pharmacokinetics and pharmacodynamics of ciprofloxacin in cystic fibrosis patients.

Authors:  M LeBel; M G Bergeron; F Vallée; C Fiset; G Chassé; P Bigonesse; G Rivard
Journal:  Antimicrob Agents Chemother       Date:  1986-08       Impact factor: 5.191

3.  Analysis of animal pharmacokinetic data: performance of the one point per animal design.

Authors:  E I Ette; A W Kelman; C A Howie; B Whiting
Journal:  J Pharmacokinet Biopharm       Date:  1995-12

4.  Clomipramine metabolism. Model-based analysis of variability factors from drug monitoring data.

Authors:  M Gex-Fabry; A E Balant-Gorgia; L P Balant; G Garrone
Journal:  Clin Pharmacokinet       Date:  1990-09       Impact factor: 6.447

5.  The pharmacokinetics of alcohol in human breath, venous and arterial blood after oral ingestion.

Authors:  E Martin; W Moll; P Schmid; L Dettli
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

6.  Propranolol pharmacokinetics during the menstrual cycle.

Authors:  I Abdu-Aguye; D Dunlop; P Patel; P Turner
Journal:  Postgrad Med J       Date:  1986-12       Impact factor: 2.401

7.  A modified pharmacokinetic model for platinum disposition in ovarian cancer patients receiving cisplatin.

Authors:  H Griffiths; M D Shelley; R G Fish
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.